Table of Contents

Introduction

Select this article
- Itamar Raz and
- Ram Weiss
The Controversies in Obesity, Diabetes and Hypertension (CODHy) Meeting: What is it all about?
Diabetes Care February 2008 31:S111-S112; doi:10.2337/dc08-s226

Section III: Obesity-The Rising Epidemic

Select this article
- Michael H. Shanik,
- Yuping Xu,
- Jan Škrha,
- Rachel Dankner,
- Yehiel Zick,
- and Jesse Roth
Insulin Resistance and Hyperinsulinemia: Is hyperinsulinemia the cart or the horse?
Diabetes Care February 2008 31:S262-S268; doi:10.2337/dc08-s264
Select this article
- Vojtĕch Hainer,
- Hermann Toplak,
- and Asimina Mitrakou
Treatment Modalities of Obesity: What fits whom?
Diabetes Care February 2008 31:S269-S277; doi:10.2337/dc08-s265
Select this article
- Peter M. Nilsson
Is Weight Loss Beneficial for Reduction of Morbidity and Mortality?: What is the controversy about?
Diabetes Care February 2008 31:S278-S283; doi:10.2337/dc08-s268
Select this article
- Owais B. Chaudhri,
- Katie Wynne,
- and Stephen R. Bloom
Can Gut Hormones Control Appetite and Prevent Obesity?
Diabetes Care February 2008 31:S284-S289; doi:10.2337/dc08-s269
Select this article
- Francesco Rubino
Is Type 2 Diabetes an Operable Intestinal Disease?: A provocative yet reasonable hypothesis
Diabetes Care February 2008 31:S290-S296; doi:10.2337/dc08-s271
Select this article
- Guntram Schernthaner and
- John M. Morton
Bariatric Surgery in Patients With Morbid Obesity and Type 2 Diabetes
Diabetes Care February 2008 31:S297-S302; doi:10.2337/dc08-s270
Select this article
- Giora Pillar and
- Naim Shehadeh
Abdominal Fat and Sleep Apnea: The chicken or the egg?
Diabetes Care February 2008 31:S303-S309; doi:10.2337/dc08-s272
Select this article
- Ram Weiss and
- Francine Ratner Kaufman
Metabolic Complications of Childhood Obesity: Identifying and mitigating the risk
Diabetes Care February 2008 31:S310-S316; doi:10.2337/dc08-s273

Introduction

The Controversies in Obesity, Diabetes and Hypertension (CODHy) Meeting: What is it all about?

Section I: Diabetes-What Is New in the Management and Understanding of the Disease?

Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 Diabetes: The role of insulin analogs

Hypoglycemia in Type 1 Diabetes: A still unresolved problem in the era of insulin analogs and pump therapy

Combined Therapy With Insulin Plus Oral Agents: Is There Any Advantage?: An argument in favor

Treatment of Type 2 Diabetes With Combined Therapy: What are the pros and cons?

Insulin as a First-Line Therapy in Type 2 Diabetes: Should the use of sulfonylureas be halted?

Long-Acting Insulin Analogs Versus Insulin Pump Therapy for the Treatment of Type 1 and Type 2 Diabetes

The Nuts and Bolts of Achieving End Points With Real-Time Continuous Glucose Monitoring

Glycemic Variability: Should we and can we prevent it?

Natural History of Cardiovascular Disease in Patients With Diabetes: Role of hyperglycemia

Islet Inflammation in Type 2 Diabetes: From metabolic stress to therapy

Is Pancreatic Diabetes (Type 3c Diabetes) Underdiagnosed and Misdiagnosed?

Section II: Diabetes Complications and Hypertension-Novel Insights into Pathophysiology and Management

NADPH Oxidases, Reactive Oxygen Species, and Hypertension: Clinical implications and therapeutic possibilities

Possible Role of Oxidative Stress in the Pathogenesis of Hypertension

Does Increased Oxidative Stress Cause Hypertension?

Albuminuria: A Great Risk Marker, but an Underestimated Target in Diabetes

Microalbuminuria in Type 2 Diabetes and Hypertension: A marker, treatment target, or innocent bystander?

Abnormal Glomerular Permeability Characteristics in Diabetic Nephropathy: Implications for the therapeutic use of low–molecular weight heparin

Primary Prevention of Cardiovascular Disease in People With Dysglycemia

Cardiovascular Complications in Diabetes: Targets and interventions

Should We Prescribe Statin and Aspirin for Every Diabetic Patient?: Is it time for a polypill?

Should We Be More Aggressive in the Therapy Against Cardiovascular Risk Factors?: Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?

Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese Patients: Pooled 1-year data from the Rimonabant in Obesity (RIO) program

Targets for Intervention in Dyslipidemia in Diabetes

Diastolic Pressure in Type 2 Diabetes: Can target systolic pressure be reached without “diastolic hypotension”?

Treatment of Diabetic Neuropathy and Neuropathic Pain: How far have we come?

Section III: Obesity-The Rising Epidemic

Insulin Resistance and Hyperinsulinemia: Is hyperinsulinemia the cart or the horse?

Treatment Modalities of Obesity: What fits whom?

Is Weight Loss Beneficial for Reduction of Morbidity and Mortality?: What is the controversy about?

Can Gut Hormones Control Appetite and Prevent Obesity?

Is Type 2 Diabetes an Operable Intestinal Disease?: A provocative yet reasonable hypothesis

Bariatric Surgery in Patients With Morbid Obesity and Type 2 Diabetes

Abdominal Fat and Sleep Apnea: The chicken or the egg?

Metabolic Complications of Childhood Obesity: Identifying and mitigating the risk

This Issue

Current Issue

From the Cover